Related Experiment Video
Updated: Feb 25, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement
Ignacio Español1, Marta Romera1, María Dolores Gutiérrez-Meca1
1Haematology Department Santa Lucía University General Hospital Cartagena Spain.
Abstract:
The dismal outcome of pleuropericardial extramedullary multiple myeloma (EMM) reflects both the selection of resistant disease and absence of useful drugs. Carfilzomib and dexamethasone should be explored in advanced EMM patients, even for bortezomib-resistant patients, as may provide much longer overall survival than previously reported treatments.
More Related Videos
Related Concept Videos
Pericarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Pericarditis IV: Nursing Management

